Truist analyst Richard Newitter raised the firm’s price target on Intuitive Surgical (ISRG) to $666 from $640 and keeps a Buy rating on the shares. The company delivered a big Q4 earnings beat, and its FY25 guidance is likely to prove “conservative” as the launch of da Vinci 5 systems is “just getting going”, the analyst tells investors in a research note. Truist adds that its expectations for 13% revenue growth and 9% EPS growth are just start points that should leave significant room for upside.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Boeing provides downbeat pre-announcement, Verizon reports Q4 beat: Morning Buzz
- Intuitive Surgical price target raised to $700 from $600 at BofA
- Intuitive Surgical price target raised to $688 from $560 at Raymond James
- Intuitive Surgical price target raised to $622 from $561 at BTIG
- Intuitive Surgical price target raised to $707 from $690 at Baird